Xiaflex for Dupuytren's positive in pilot using convenient multiple injections
This article was originally published in Scrip
Executive Summary
Auxilium Pharmaceuticals has reported positive top-line results from a pilot clinical study for the treatment of Dupuytren's contracture. The study was examining the feasibility of using its novel therapy Xiaflex (collagenase from Clostridium histolyticum) to treat multiple (two) of the fibrous cords that characterise patients with Dupuytren's contracture at the same time.